Free chickenpox vaccination offered for the first time to children

Source: UK Health Security Agency, 29 August 2025

• Government to launch chickenpox vaccination programme in England from January 2026, which will protect around half a million children each year
• Eligible children will receive the vaccine during routine GP appointments, which protects against measles, mumps, rubella and chickenpox
• The rollout will help raise the healthiest generation of children ever, while reducing sick days and time parents take off work

Thousands of children will be protected against chickenpox for the first time in England through a new vaccination programme that will keep kids in school and parents in work while also saving the NHS vital funds.

From January next year, GP practises will offer eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) – the clinical term for chickenpox – as part of the routine infant vaccination schedule.

It will mean kids miss fewer days in nursery and school while parents won’t need to take time off work to care for them. Research shows that chickenpox in childhood results in an estimated £24 million in lost income and productivity every year in the UK. The rollout will also save the NHS £15 million a year in costs for treating the common condition.

The chickenpox vaccine has been safely used for decades and is already part of the routine vaccine schedules in several countries, including the United States, Canada, Australia and Germany.

The vaccination programme forms part of the government’s wider ambition to raise the healthiest generation of children ever as part of our Plan for Change — boosting the nation’s health and ensuring the future sustainability of the NHS as we shift the focus of healthcare from sickness to prevention.

The vaccine will help reduce cases of chickenpox and protect children from serious complications that can cause hospitalisation, such as bacterial infections like strep A, brain and lung inflammation and stroke.

The government’s decision to roll out the MMRV vaccine in January is based on expert scientific advice from the Joint Committee on Vaccination and Immunisation (JCVI), following research showing the significant impact of severe cases of chickenpox on children’s health, hospital admissions and associated costs.